These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2551461)

  • 1. Neuropeptide Y-induced effects on hypothalamic corticotropin-releasing factor content and release are dependent on noradrenergic/adrenergic neurotransmission.
    Haas DA; George SR
    Brain Res; 1989 Oct; 498(2):333-8. PubMed ID: 2551461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide Y administration acutely increases hypothalamic corticotropin-releasing factor immunoreactivity: lack of effect in other rat brain regions.
    Haas DA; George SR
    Life Sci; 1987 Dec; 41(25):2725-31. PubMed ID: 2826949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential alpha-1 and alpha-2 adrenergic effects on hypothalamic corticotropin-releasing factor and plasma adrenocorticotropin.
    Haas DA; Sturtridge WC; George SR
    Neuroscience; 1990; 38(3):693-701. PubMed ID: 1980144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of hypothalamic norepinephrine depletion on median eminence CRF-41 content and serum ACTH in control and adrenalectomized rats.
    Weidenfeld J; Feldman S
    Brain Res; 1991 Mar; 542(2):201-4. PubMed ID: 1851452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of dopaminergic and alpha-adrenergic modulation on corticotropin-releasing factor immunoreactivity in rat hypothalamus.
    Haas DA; George SR
    Can J Physiol Pharmacol; 1988 Jun; 66(6):754-61. PubMed ID: 2901903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time course study on the effect of reserpine on hypothalamic immunoreactive CRF levels in rats.
    Suda T; Tomori N; Yajima F; Sumitomo T; Nakagami Y; Ushiyama T; Demura H; Shizume K
    Brain Res; 1987 Mar; 405(2):247-52. PubMed ID: 3032352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypothalamic norepinephrine depletion inhibits CRF-41 release following neural stimuli.
    Feldman S; Weidenfeld J
    Neuroreport; 1993 Dec; 5(3):258-60. PubMed ID: 8298085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptide-Y stimulates CRF-41 release from rat hypothalami in vitro.
    Tsagarakis S; Rees LH; Besser GM; Grossman A
    Brain Res; 1989 Nov; 502(1):167-70. PubMed ID: 2819453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NPY Y1 receptors exert opposite effects on corticotropin releasing factor and noradrenaline overflow from the rat hypothalamus in vitro.
    Hastings JA; McClure-Sharp JM; Morris MJ
    Brain Res; 2001 Jan; 890(1):32-7. PubMed ID: 11164766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single or repeated mild stress increases synthesis and release of hypothalamic corticotropin-releasing factor.
    Haas DA; George SR
    Brain Res; 1988 Oct; 461(2):230-7. PubMed ID: 2846119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide Y increases the corticotropin-releasing factor messenger ribonucleic acid level in the rat hypothalamus.
    Suda T; Tozawa F; Iwai I; Sato Y; Sumitomo T; Nakano Y; Yamada M; Demura H
    Brain Res Mol Brain Res; 1993 Jun; 18(4):311-5. PubMed ID: 8392133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of protein synthesis inhibition on brain corticotropin-releasing factor and plasma adrenocorticotropin.
    Haas DA; Sturtridge WC; George SR
    Can J Physiol Pharmacol; 1990 Dec; 68(12):1595-600. PubMed ID: 1964865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II and adrenocorticotropin release: mediation by endogenous corticotropin-releasing factor.
    Spinedi E; Rodriguez G
    Endocrinology; 1986 Sep; 119(3):1397-402. PubMed ID: 3015575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the hypothalamo-corticotrope axis after bilateral adrenalectomy: evidence for a median eminence site of glucocorticoid action.
    Spinedi E; Giacomini M; Jacquier MC; Gaillard RC
    Neuroendocrinology; 1991 Feb; 53(2):160-70. PubMed ID: 1849620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of paraventricular lesions on corticotropin-releasing factor (CRF)-like immunoreactivity in the stalk-median eminence: studies on the adrenocorticotropin response to ether stress and exogenous CRF.
    Bruhn TO; Plotsky PM; Vale WW
    Endocrinology; 1984 Jan; 114(1):57-62. PubMed ID: 6317350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gonadal regulation of corticotropin-releasing factor immunoreactivity in hypothalamus.
    Haas DA; George SR
    Brain Res Bull; 1988 Mar; 20(3):361-7. PubMed ID: 3284608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular effects and modulation of noradrenergic neurotransmission following central and peripheral administration of neuropeptide Y.
    Westfall TC; Martin J; Chen XL; Ciarleglio A; Carpentier S; Henderson K; Knuepfer M; Beinfeld M; Naes L
    Synapse; 1988; 2(3):299-307. PubMed ID: 2850631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoreactive corticotropin-releasing factor in rat plasma.
    Sumitomo T; Suda T; Tomori N; Yajima F; Nakagami Y; Ushiyama T; Demura H; Shizume K
    Endocrinology; 1987 Apr; 120(4):1391-6. PubMed ID: 3030699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estradiol or ovariectomy decreases CRF synthesis in hypothalamus.
    Haas DA; George SR
    Brain Res Bull; 1989 Sep; 23(3):215-8. PubMed ID: 2555031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin-releasing peptide releases corticotropin-releasing hormone and increases plasma adrenocorticotropin via the paraventricular nucleus of the hypothalamus.
    Seal LJ; Small CJ; Dhillo WS; Kennedy AR; Ghatei MA; Bloom SR
    Neuroendocrinology; 2002 Aug; 76(2):70-8. PubMed ID: 12169768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.